spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoki, H.
Right arrow Articles by Miyazono, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoki, H.
Right arrow Articles by Miyazono, K.

Journal of Cell Science, Vol 114, Issue 8 1483-1489, Copyright © 2001 by Company of Biologists


JOURNAL ARTICLES

Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction

H Aoki, M Fujii, T Imamura, K Yagi, K Takehara, M Kato and K Miyazono
Dept of Biochemistry, The JFCR Cancer Institute, and Research for the Future Program, the Japan Society for the Promotion of Science, Toshima-ku, Tokyo 170-8455, Japan. miyazono-ind@umin.ac.jp

Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-(&bgr;) superfamily, which regulate the differentiation of osteoprogenitor cells. Here we show that among members of the BMP family, BMP-4 and growth/differentiation factor 5 (GDF-5) induce osteoblast differentiation through the activation of three receptor-regulated Smads (i.e. Smad1, Smad5 and Smad8). By contrast, BMP-6 and BMP-7 induce alkaline phosphatase activity through Smad1 and Smad5, but not through Smad8. Consistent with these findings, BMP-4 induced phosphorylation and nuclear translocation of Smad1, Smad5 and Smad8, but BMP-6 activated only Smad1 and Smad5. BMP-4 and GDF-5 are known to bind to activin receptor-like kinase 3 (ALK-3) and/or ALK-6 (also termed BMP type IA and type IB receptors, respectively), whereas BMP-6 and BMP-7 preferentially bind to ALK-2. Compared with the effects induced by only one of the type I receptors, the combination of constitutively active forms of ALK-2 and ALK-3 (or ALK-6) more strongly induced alkaline phosphatase activity in C2C12 cells. Moreover, addition of BMP-4 and BMP-6 to C2C12 cells resulted in higher alkaline phosphatase activity than that of only one of these BMPs. The combination of ALK-2 and ALK-3 also induced higher transcriptional activity than either receptor alone. Thus, ALK-2 and ALK-3 (or ALK-6) might synergistically induce osteoblast differentiation of C2C12 cells, possibly through efficient activation of downstream signaling pathways.


This article has been cited by other articles:


Home page
J. Dent. Res.Home page
J.T. Koh, Z. Zhao, Z. Wang, I.S. Lewis, P.H. Krebsbach, and R.T. Franceschi
Combinatorial Gene Therapy with BMP2/7 Enhances Cranial Bone Regeneration
J. Dent. Res., September 1, 2008; 87(9): 845 - 849.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Lavery, P. Swain, D. Falb, and M. H. Alaoui-Ismaili
BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells
J. Biol. Chem., July 25, 2008; 283(30): 20948 - 20958.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T. Miyoshi, F. Otsuka, H. Otani, K. Inagaki, J. Goto, M. Yamashita, T. Ogura, Y. Iwasaki, and H. Makino
Involvement of bone morphogenetic protein-4 in GH regulation by octreotide and bromocriptine in rat pituitary GH3 cells
J. Endocrinol., April 1, 2008; 197(1): 159 - 169.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. D. Upton, L. Long, R. C. Trembath, and N. W. Morrell
Functional Characterization of Bone Morphogenetic Protein Binding Sites and Smad1/5 Activation in Human Vascular Cells
Mol. Pharmacol., February 1, 2008; 73(2): 539 - 552.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
R. J. Wordinger and A. F. Clark
Bone Morphogenetic Proteins and Their Receptors in the Eye
Experimental Biology and Medicine, September 1, 2007; 232(8): 979 - 992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Goto, Y. Kamiya, T. Imamura, K. Miyazono, and K. Miyazawa
Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors
J. Biol. Chem., July 13, 2007; 282(28): 20603 - 20611.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Scherner, S. K. Meurer, L. Tihaa, A. M. Gressner, and R. Weiskirchen
Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-beta1 and BMP-7 Signaling
J. Biol. Chem., May 11, 2007; 282(19): 13934 - 13943.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Otani, F. Otsuka, K. Inagaki, M. Takeda, T. Miyoshi, J. Suzuki, T. Mukai, T. Ogura, and H. Makino
Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1513 - F1525.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K. B Lee, V. Khivansara, M. M Santos, P. Lamba, T. Yuen, S. C Sealfon, and D. J Bernard
Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone {beta} subunit transcription
J. Mol. Endocrinol., February 1, 2007; 38(2): 315 - 330.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Miyoshi, F. Otsuka, K. Inagaki, H. Otani, M. Takeda, J. Suzuki, J. Goto, T. Ogura, and H. Makino
Differential Regulation of Steroidogenesis by Bone Morphogenetic Proteins in Granulosa Cells: Involvement of Extracellularly Regulated Kinase Signaling and Oocyte Actions in Follicle-Stimulating Hormone-Induced Estrogen Production
Endocrinology, January 1, 2007; 148(1): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Inagaki, F. Otsuka, J. Suzuki, Y. Kano, M. Takeda, T. Miyoshi, H. Otani, Y. Mimura, T. Ogura, and H. Makino
Involvement of Bone Morphogenetic Protein-6 in Differential Regulation of Aldosterone Production by Angiotensin II and Potassium in Human Adrenocortical Cells
Endocrinology, June 1, 2006; 147(6): 2681 - 2689.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. Miyoshi, F. Otsuka, J. Suzuki, M. Takeda, K. Inagaki, Y. Kano, H. Otani, Y. Mimura, T. Ogura, and H. Makino
Mutual Regulation of Follicle-Stimulating Hormone Signaling and Bone Morphogenetic Protein System in Human Granulosa Cells
Biol Reprod, June 1, 2006; 74(6): 1073 - 1082.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. C Jayawardana, T. Shimizu, H. Nishimoto, E. Kaneko, M. Tetsuka, and A. Miyamoto
Hormonal regulation of expression of growth differentiation factor-9 receptor type I and II genes in the bovine ovarian follicle.
Reproduction, March 1, 2006; 131(3): 545 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-H. Yew, M. Hembree, K. Prasadan, B. Preuett, C. McFall, C. Benjes, A. Crowley, S. Sharp, S. Tulachan, S. Mehta, et al.
Cross-talk between Bone Morphogenetic Protein and Transforming Growth Factor-{beta} Signaling Is Essential for Exendin-4-induced Insulin-positive Differentiation of AR42J Cells
J. Biol. Chem., September 16, 2005; 280(37): 32209 - 32217.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. S. Yoon, D. A. Ovchinnikov, I. Yoshii, Y. Mishina, R. R. Behringer, and K. M. Lyons
Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo
PNAS, April 5, 2005; 102(14): 5062 - 5067.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
J.L. Juengel and K.P. McNatty
The role of proteins of the transforming growth factor-{beta} superfamily in the intraovarian regulation of follicular development
Hum. Reprod. Update, March 1, 2005; 11(2): 144 - 161.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Takeda, F. Otsuka, K. Nakamura, K. Inagaki, J. Suzuki, D. Miura, H. Fujio, H. Matsubara, H. Date, T. Ohe, et al.
Characterization of the Bone Morphogenetic Protein (BMP) System in Human Pulmonary Arterial Smooth Muscle Cells Isolated from a Sporadic Case of Primary Pulmonary Hypertension: Roles of BMP Type IB Receptor (Activin Receptor-Like Kinase-6) in the Mitotic Action
Endocrinology, September 1, 2004; 145(9): 4344 - 4354.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Brederlau, R. Faigle, M. Elmi, A. Zarebski, S. Sjoberg, M. Fujii, K. Miyazono, and K. Funa
The Bone Morphogenetic Protein Type Ib Receptor Is a Major Mediator of Glial Differentiation and Cell Survival in Adult Hippocampal Progenitor Cell Culture
Mol. Biol. Cell, August 1, 2004; 15(8): 3863 - 3875.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. Shimasaki, R. K. Moore, F. Otsuka, and G. F. Erickson
The Bone Morphogenetic Protein System In Mammalian Reproduction
Endocr. Rev., February 1, 2004; 25(1): 72 - 101.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino
Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells
Endocrinology, February 1, 2004; 145(2): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Hay, J. Lemonnier, O. Fromigue, H. Guenou, and P. J. Marie
Bone Morphogenetic Protein Receptor IB Signaling Mediates Apoptosis Independently of Differentiation in Osteoblastic Cells
J. Biol. Chem., January 16, 2004; 279(3): 1650 - 1658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-X. Ying, Z. J. Hussain, and Y. E. Zhang
Smurf1 Facilitates Myogenic Differentiation and Antagonizes the Bone Morphogenetic Protein-2-induced Osteoblast Conversion by Targeting Smad5 for Degradation
J. Biol. Chem., October 3, 2003; 278(40): 39029 - 39036.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
Y. Hatakeyama, J. Nguyen, X. Wang, G. H. Nuckolls, and L. Shum
Smad Signaling in Mesenchymal and Chondroprogenitor Cells
J. Bone Joint Surg. Am., August 1, 2003; 85(90003): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. Canalis, A. N. Economides, and E. Gazzerro
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Endocr. Rev., April 1, 2003; 24(2): 218 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Moore, F. Otsuka, and S. Shimasaki
Molecular Basis of Bone Morphogenetic Protein-15 Signaling in Granulosa Cells
J. Biol. Chem., January 3, 2003; 278(1): 304 - 310.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. P. Raju, N. Dimova, P. S. Klein, and H.-C. Huang
SANE, a Novel LEM Domain Protein, Regulates Bone Morphogenetic Protein Signaling through Interaction with Smad1
J. Biol. Chem., January 3, 2003; 278(1): 428 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
J. Skillington, L. Choy, and R. Derynck
Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes
J. Cell Biol., October 14, 2002; 159(1): 135 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Valcourt, J. Gouttenoire, A. Moustakas, D. Herbage, and F. Mallein-Gerin
Functions of Transforming Growth Factor-beta Family Type I Receptors and Smad Proteins in the Hypertrophic Maturation and Osteoblastic Differentiation of Chondrocytes
J. Biol. Chem., September 6, 2002; 277(37): 33545 - 33558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Nishihara, T. Watabe, T. Imamura, and K. Miyazono
Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary Hypertension
Mol. Biol. Cell, September 1, 2002; 13(9): 3055 - 3063.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Gaussin, T. Van de Putte, Y. Mishina, M. C. Hanks, A. Zwijsen, D. Huylebroeck, R. R. Behringer, and M. D. Schneider
Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3
PNAS, February 14, 2002; (2002) 42390499.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Gaussin, T. Van de Putte, Y. Mishina, M. C. Hanks, A. Zwijsen, D. Huylebroeck, R. R. Behringer, and M. D. Schneider
Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3
PNAS, March 5, 2002; 99(5): 2878 - 2883.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2001